YOLFTbeta
Waldencast plc

Waldencast plc

WALD · NASDAQ · Consumer Defensive / Household & Personal Products

0.8794USD+0.03 (+3.45%)

Price History

Full chart

Market Stats

Previous Close0.8501
Open0.8794
Day Range0.8794 – 0.8794
52-Week Range0.72 – 3.22
Volume277.02K
Market Cap132.11M
P/E (TTM)0.00
Forward P/E45.05
EPS-2.01
Dividend Yield0.00%
Beta-0.07
50-Day Avg1.41
200-Day Avg1.50

About

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as well as sells liner, eyeshadow, and lip color products. It serves distributors, retailers, physicians, and directly to consumers through its e-commerce platforms, and third-party logistics and delivery providers. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Company Details

  • SectorConsumer Defensive
  • IndustryHousehold & Personal Products
  • CEOMr. Felipe Dutra
  • Employees367
  • Headquarters81 Fulham Road, London, United Kingdom, SW3 6RD, USA
  • Websitehttps://www.waldencast.com

Leadership

  • Mr. Felipe DutraChairman of the Board, Principal Executive & Financial Officer & Interim CEO · b. 1965
  • Ms. Elisabeth MilanGeneral Counsel

Financials

Income Statement

Currency: USD2020-12-312021-12-312023-12-312024-12-312025-12-31
Total Revenue94.43M142.47M218.14M273.87M272.07M
Growth (%)-+50.88%+53.11%+25.55%-0.66%
Cost of Revenue29.10M55.04M76.56M82.12M148.24M
Gross Profit65.33M87.44M141.58M131.73M123.83M
Gross Margin69.19%61.37%64.90%48.10%45.52%
Operating Expense64.80M89.06M223.51M190.31M185.51M
Operating Income528.00K-1.63M-81.93M-58.58M-61.67M
Operating Margin0.56%-1.14%-37.56%-21.39%-22.67%
EBITDA13.94M15.05M-33.54M28.63M-2.49M
EBITDA Margin14.76%10.56%-15.38%10.45%-0.92%
Net Income-2.37M-19.58M-89.98M-42.44M-229.75M
Net Income Margin-2.51%-13.74%-41.25%-15.50%-84.44%
R&D4.38M6.09M3.19M--
R&D as % of Total Revenue4.64%4.28%1.46%--
Interest Expense6.28M11.12M18.91M17.16M25.09M
Interest Expense % of Total Revenue6.65%7.80%8.67%6.26%9.22%

Balance Sheet

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets166.79K184.59M1.09B1.04B975.86M816.20M
Total Liabilities177.74K145.35M290.18M273.44M245.92M316.10M
Total Equity-10.95K39.24M799.90M624.63M662.32M461.88M
Cash012.79M8.69M22.58M14.80M31.89M
Total Debt-118.86M-177.72M182.11M149.01M
Net Debt-106.07M170.63M155.15M167.30M117.12M

Cash Flow

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-7.43M3.53M--29.77M-8.82M-12.82M
Investing Cash Flow-1.71M-3.79M--1.99M-2.92M76.23M
Financing Cash Flow14.32M5.16M-44.33M5.58M-47.22M
Capital Expenditure1.71M1.29M02.05M3.01M3.43M
Free Cash Flow-9.14M2.24M--31.82M-11.83M-16.25M
Dividends Paid2.04M2.00M-0--
FCF to OCF122.97%63.53%-106.87%134.15%126.76%
Dividend Paid to FCF-22.37%89.21%-0.00%--

Earnings

Report DateMar 31, 2021Jun 30, 2021Jul 19, 2021Nov 18, 2021Mar 31, 2022May 16, 2022Aug 11, 2022Nov 10, 2022Mar 15, 2023Apr 26, 2023Aug 10, 2023Nov 9, 2023Jan 16, 2024May 21, 2024Aug 27, 2024Nov 20, 2024Mar 20, 2025May 13, 2025Sep 25, 2025Dec 30, 2025Jan 20, 2026Jun 26, 2026
EPS Estimate0.000.00----0.100.01-0.01-0.010.07-0.05-0.01-0.01-0.03-0.05-0.05-0.04-0.07-0.11-0.11-0.12
EPS Actual-0.03-0.04-0.030.18-0.440.070.06-0.060.030.030.070.00-0.49-0.49-0.05-0.09-0.28-0.17-0.09-0.110.000.00
Surprise-------40.00%-700.00%350.00%350.00%4.71%100.00%-4800.00%-4800.00%-66.67%-80.00%-434.35%-347.37%-28.57%0.00%100.00%100.00%
Timing----After-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market--Pre-marketPre-marketAfter-hours---After-hoursPre-marketPre-market-

Key Statistics & Ratios

Market Cap132.11M
Enterprise Value251.38M
Trailing P/E0.00
Forward P/E45.05
Price / Sales0.49
Price / Book0.29
EPS-2.01
Book Value3.91
Revenue (TTM)272.07M
Gross Profit (TTM)183.02M
EBITDA-5.78M
Profit Margin-84.45%
Operating Margin-22.48%
Return on Equity-40.33%
Return on Assets-4.72%
Shares Outstanding118.24M
Shares Float46.04M
Beta-0.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 6 analystsTarget 2.05
  • Strong Buy
    4
  • Hold
    2

Ownership Breakdown

Institutions
24.24%
Insiders
51.02%
Retail / Other
24.74%

Top Institutional Holders

  • Zeno Equity Partners LLP
    12.25M9.55%
  • Milestones Administradora de Recursos LTDA.
    2.43M1.89%
  • BlackRock Inc
    1.99M1.55%
  • Stoic Point Capital Management LLC
    1.64M1.28%
  • Geode Capital Management, LLC
    647.32K0.50%
  • Millennium Management LLC
    577.01K0.45%
  • State Street Corp
    547.12K0.43%
  • Beartown Capital Management, LLC
    300.00K0.23%
  • Vanguard Portfolio Management, LLC
    280.09K0.22%
  • Northern Trust Corp
    246.87K0.19%
  • The Goldman Sachs Group Inc
    170.99K0.13%
  • Aster Capital Management (DIFC) Ltd
    132.45K0.10%
  • Charles Schwab Investment Management Inc
    106.17K0.08%
  • Bank of New York Mellon Corp
    106.11K0.08%
  • UBS Group AG
    82.95K0.06%
  • SmartHarvest Portfolios, LLC
    64.81K0.05%
  • Nuveen, LLC
    56.63K0.04%
  • Rhumbline Advisers
    54.24K0.04%

Top Fund Holders

  • More Stacx FIM C Priv IE
    119.08K0.09%
  • Fidelity Nasdaq Composite Index
    74.30K0.06%